CC2022: Return to Baseline Physical Activity After Bone–Patellar Tendon–Bone Versus Hamstring Tendon Autografts for Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis of Randomized Controlled Trials (July 2022)-CC2022: Return to Baseline Physical Activity After Bone–Patellar Tendon–Bone Versus Hamstring Tendon Autografts for Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis of Randomized Controlled Trials (July 2022)

CC2022: Return to Baseline Physical Activity After Bone–Patellar Tendon–Bone Versus Hamstring Tendon Autografts for Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis of Randomized Controlled Trials (July 2022)

Back to course

Pdf Summary

A systematic review and meta-analysis of randomized controlled trials compared the use of bone-patellar tendon-bone (BPTB) and hamstring tendon (HT) autografts for anterior cruciate ligament (ACL) reconstruction. The study assessed the effects of autograft choice on return to baseline level of physical activity and/or sports participation, knee stability testing, and clinical subjective knee scores. A total of 29 studies were eligible for review, with 13 studies reporting on return to baseline level of sports. The results showed no significant difference in return to baseline sport level between BPTB and HT autografts. However, there was a statistically significant difference in favor of BPTB autografts for the absence of a positive pivot-shift test. The study concluded that no recommendation can be made on the optimal graft choice for return to baseline level of physical activity and/or sports participation. It advised that higher quality randomized controlled trials should be conducted to confirm these findings and provide further evidence for graft choice in ACL reconstruction.

Keywords

systematic review

meta-analysis

randomized controlled trials

bone-patellar tendon-bone

hamstring tendon

ACL reconstruction

physical activity

sports participation

knee stability testing

graft choice